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a b s t r a c t
The ﬁrst lineage segregation in the mouse embryo generates the inner cell mass (ICM), which gives rise
to the pluripotent epiblast and therefore the future embryo, and the trophectoderm (TE), which will
build the placenta. The TE lineage depends on the transcription factor Cdx2. However, when Cdx2 ﬁrst
starts to act remains unclear. Embryos with zygotic deletion of Cdx2 develop normally until the late
blastocyst stage leading to the conclusion that Cdx2 is important for the maintenance but not
speciﬁcation of the TE. In contrast, down-regulation of Cdx2 transcripts from the early embryo stage
results in defects in TE speciﬁcation before the blastocyst stage. Here, to unambiguously address at
which developmental stage Cdx2 becomes ﬁrst required, we genetically deleted Cdx2 from the oocyte
stage using a Zp3-Cre/loxP strategy. Careful assessment of a large cohort of Cdx2 maternal-zygotic null
embryos, all individually ﬁlmed, examined and genotyped, reveals an earlier lethal phenotype than
observed in Cdx2 zygotic null embryos that develop until the late blastocyst stage. The developmental
failure of Cdx2maternal-zygotic null embryos is associated with cell death and failure of TE speciﬁcation,
starting at the morula stage. These results indicate that Cdx2 is important for the correct speciﬁcation of
TE from the morula stage onwards and that both maternal and zygotic pools of Cdx2 are required for
correct pre-implantation embryogenesis.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
Introduction
Prior to zygotic genome activation (ZGA), embryonic develop-
ment is dependent on maternally inherited RNAs and proteins
(Bachvarova and De Leon, 1980; Braude et al., 1979; Cascio and
Wassarman, 1982; Van Blerkom, 1981). In the mouse, there are
two waves of ZGA: a minor one at the late zygote stage and a
major one at the 2-cell stage (Flach et al., 1982; Latham and
Schultz, 2001). Despite this early ZGA, maternal factors are
recognised as essential for embryo viability and also lineage
segregation (Keramari et al., 2010; Zuccotti et al., 2011). Maternal
factors can either rescue or signiﬁcantly delay development of the
mutant phenotype in zygotic knockout embryos (Avilion et al.,
2003; Larue et al., 1994; Reithmacher et al., 1995). It is therefore
important to consider the contribution of both maternal and
zygotic gene expression to embryo development, particularly at
the pre-implantation stages.
The ﬁrst lineage segregation in the mouse embryo leads to
separation of inside and outside cells that occurs in two cell division
waves: at the 8–16 cell and 16–32 cell transition (Bischoff et al.,
2008; Graham and Deussen, 1978; Johnson and Ziomek, 1982;
Pedersen et al., 1986). Inside and outside cells will develop their
unique identity due to their differential position and due to asym-
metric partitioning of cell polarity proteins, such as Par1, Par3, aPKC,
Jam1, Ezrin and transcripts, such as Cdx2 (Louvet et al., 1996;
Nishioka et al., 2009; Skamagki et al., 2013; Tarkowski and
Wroblewska, 1967; Thomas et al., 2004; Vinot et al., 2005). Together
differential partitioning of key cellular components and differential
cell positioning establish the inside–outside asymmetry within the
embryo that leads to development of the ICM and TE lineages.
Cdx2 is an essential transcription factor for the development of
the mouse embryo at many developmental stages (Gao et al., 2009;
Grainger et al., 2010; Morris et al., 2014; Stringer et al., 2012; van
Rooijen et al., 2012; Zhao et al., 2014). During pre-implantation
development, Cdx2 is essential for the TE lineage, but the stage of
development at which Cdx2 plays a role and the processes it controls
both remain unclear. Embryos with zygotic deletion of Cdx2 develop
normally until the late blastocyst stage leading to the suggestion that
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Cdx2 is involved only in maintenance of the TE lineage (Ralston and
Rossant, 2008; Strumpf et al., 2005). However, down-regulation of
both maternal and zygotic Cdx2 expression by RNAi or morpholino
treatments results in a much earlier phenotype that includes defects
in cell polarisation, developmental arrest (Jedrusik et al., 2010) and
the abnormal activity of mitochondria (Wu et al., 2010). These studies
led to the suggestion that Cdx2 might have two roles in pre-
implantation development: ﬁrst, to ensure appropriate cell polarisa-
tion that is critical for TE formation and second, the subsequent
maintenance of the TE lineage.
Functionality of maternal Cdx2 was recently questioned as
embryos in which maternal Cdx2 expression was genetically
eliminated developed normally (Blij et al., 2012). Here, to
address this discrepancy we have genetically ablated both
maternal and zygotic Cdx2 and ﬁlmed development of Cdx2
maternal-zygotic and Cdx2 maternal and Cdx2 zygotic knockout
embryos side-by-side to compare development to the blastocyst
stage. This revealed that embryos deﬁcient for both maternal
and zygotic Cdx2 show signiﬁcantly reduced developmental
potential and increased cell death from the morula stage
onwards. The developmental lethality is signiﬁcantly stronger
following depletion of both maternal and zygotic pools of Cdx2,
rather than when only maternal or only zygotic Cdx2 are
eliminated. Together, these results lead us to conclude that both
maternal and zygotic Cdx2 are important for the development of
the mouse embryo and that the ﬁrst stage of development at
which Cdx2 plays a role is at the morula stage when speciﬁcation
of the TE ﬁrst starts.
Materials and methods
Mouse strains
To obtain oocytes depleted of maternal Cdx2, we used females
heterozygous for a ﬂoxed Cdx2 gene (Gao et al., 2009) and a Cdx2
deletion (Cdx2Δ), and carrying a Zp3-Cre transgene (de Vries et al.,
2000) (Cdx2loxP/Cdx2Δ; Zp3-Cre females). These females were mated
with Cdx2loxP/Cdx2Δmales (Fig. 1). The Cdx2loxP line (Gao et al., 2009)
was a kind gift from Klaus H Kaestner. Complete cleavage of the
Cdx2loxP allele in the female germline by Cre recombinase results in
100% of mature oocytes carrying the Cdx2Δ. 50% of the resulting
embryos that are Cdx2Δ/Cdx2Δ are maternal-zygotic knockouts (MZ-
KO) and the 50% Cdx2Δ/Cdx2loxP embryos that have a wild-type (but
ﬂoxed) paternal Cdx2 allele are heterozygous maternal knockouts
(M-KO). Control females were either Cdx2loxP homozygotes or
Cdx2loxP/Cdx2Δ heterozygotes and did not carry the Zp3-Cre trans-
gene. To obtain embryos depleted of zygotic Cdx2 (Z-KO), mice
heterozygous for the Cdx2 targeted mutation Cdx2tm1Fbe that we refer
to as Cdx2- were intercrossed (MGI:1857928) (Chawengsaksophak
et al., 1997).
Embryo recovery, culture and time-lapse microscopy
Mouse embryos were recovered from oviducts of superovu-
lated females (10 IU PMSG, 10 IU hCG; Intervet), collected into M2
medium with 4 mg/ml BSA, and cultured in KSOM supplemented
with 4 mg/ml BSA as described before (Jedrusik et al., 2008). To
record the development of each individual embryo, embryos were
cultured on gridded dishes and ﬁlmed by time-lapse microscopy.
Imaging was non-invasive and carried out using a wide-ﬁeld Zeiss
microscope with a Hamamatsu Orca ER digital camera and DIC Z-
stacks were collected at 15 min intervals for 58 h.
To analyse any occurrence of cell death during embryo devel-
opment, SYTOX ﬂuorescent green nucleic acid stain (Life technol-
ogies) was added to the culture medium as previously described
(Bedzhov and Zernicka-Goetz, 2014).
Individual embryo immunoﬂuorescence and genotyping
Individual embryos were removed from the gridded dish upon
completion of time-lapse imaging, ﬁxed individually in 4% PFA
(4 1C, 12 h) and processed for immunoﬂuorescence as previously
described (Plusa et al., 2005). Primary antibodies: mouse anti-
Cdx2 (BioGenex; 1:200), rat TROMA-1 anti-cytokeratin-8 (DSHB,
Iowa; 1:100); and rabbit anti-Nanog (R&D Systems; 1:200). DNA
was stained with Hoechst (Sigma). Images were recorded using a
Leica SP5 confocal microscope with a 40 oil objective.
Following immunoﬂuorescence, the genotype of each embryo
was determined by PCR. To this end, genomic DNA was extracted
from individual embryos in 10 ml extraction/neutralization buffers
(Truett et al., 2000). 4.5–5 ml of the lysate was used in PCR
reactions using the Fast Cycling PCR Kit (Qiagen) and primers:
50-GACCGAAGTCTGCAGAACCT and 50-GGCTCAGGACTTGCTCCTTCA
to detect Cdx2 WT and Cdx2 KO alleles; and 50-AGCCCATTGCTG-
GACGGAGG and 50-CCGCTTACCTTGACGCCACA to detect cleaved
KO (null) allele.
Results
Cdx2 is required for correct development to the blastocyst stage
in vivo
The stage at which Cdx2 is ﬁrst required for development of the
mouse embryo remains unclear because Cdx2 is expressed both
maternally and zygotically (Jedrusik et al., 2010; Wu et al., 2010).
To address this, we used a genetic approach to deplete maternal
and zygotic pools of Cdx2 from the oocyte stage onwards by
crossing females heterozygous for a ﬂoxed Cdx2 gene and a Cdx2
deletion and carrying the Cre-recombinase gene under control of
the ZP3 promotor (Cdx2loxP/Cdx2Δ; Zp3-Cre) with Cdx2loxP/Cdx2Δ
Fig. 1. Breeding schemes used to generate Cdx2 maternal-zygotic knockout and
maternal knockout embryos.
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males (Fig. 1). This cross results in equal proportions of homo-
zygotes for the Cdx2 deletion and heterozygotes with one deleted
copy and one ﬂoxed copy. We ﬁrst allowed the embryos to develop
in utero and recovered them 3.75 days after fertilisation when they
should have reached the mature blastocyst stage. To ensure that
the embryos were of the highest possible quality, embryos were
Fig. 2. (A) Development of Cdx2 maternal-zygotic null embryos in vivo and in vitro. Summary of data on the frequency of blastocyst formation in embryos developing in
utero. Experimental embryos are progeny of Cdx2loxP/Cdx2Δ; Zp3-cremothers, and control group 1 Cdx2loxP/ Cdx2loxP mothers, in both cases crossed to Cdx2loxP/Cdx2Δ fathers.
The embryos were recovered at E3.75. The average number of cells were as follows: control embryos (Cdx2loxP/Cdx2loxP), 60.5; control embryos (Cdx2loxP/Cdx2Δ), 63.4;
maternal knockout embryos (Cdx2loxP/Cdx2Δ), 43.4; maternal-zygotic knockout embryos (Cdx2Δ/Cdx2Δ ), 29.0. Embryo morphology was assessed immediately after
recovery after which embryos were ﬁxed, stained and genotyped. (B) Schematic representation of experimental design for culturing, time-lapse imaging and genotyping
individual embryos. (C) Summary of data on the frequency of blastocyst formation in embryos developing in vitro. Control group 2 is progeny of Cdx2loxP parents; control
group 3, are embryos from Cdx2þ/ intercrosses. (D) Examples of embryo development from 4-cell to the blastocyst stage in control (upper panel) and maternal-zygotic
knockout (MZ-KO) embryos (lower panels). Dying cells indicated with white arrows. Bar¼25 μm. (E) Still images of time-lapse recording of pre-implantation development of
Cdx2MZ-KO (top two panels) and control (bottom panel) embryos. Dying cells are marked by SYTOX, a ﬂuorescent green cell death reporter. Cell death in MZ-KO embryos is
initiated at earlier developmental stages than in control embryos and with signiﬁcantly higher frequency. Bar¼25 μm.
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recovered from naturally mated rather than super-ovulated
females. We found that none of the Cdx2 maternal-zygotic knock-
out embryos (0 out of 8, 0%) developed to the blastocyst stage
(Fig. 2A). This was in contrast to their heterozygous siblings, Cdx2
maternal-knockout embryos, where 6 out of 10 (60%) embryos
developed to the blastocyst stage. In a control group of embryos
from Cdx2loxP/Cdx2loxP mothers lacking the ZP3-Cre transgene, 15
out of 17 (88%) progressed to the blastocyst stage. Thus, deﬁciency
of maternal and zygotic Cdx2 expression leads to an earlier lethal
phenotype than observed for the Cdx2 zygotic knockout alone
Fig. 3. Aberrant trophectoderm speciﬁcation in embryos lacking maternal and zygotic expression of Cdx2. (A) Expression of trophectoderm (TE) speciﬁc cytokeratins,
recognised by TROMA-1 antibody, is reduced in Cdx2 MZ-KO (N¼6) and M-KO (N¼7) embryos in comparison to both heterozygous (N¼4) and homozygous (N¼4) controls
allowed to develop for the same time period (4.5 days post-fertilisation). Fluorescent signal intensity was quantiﬁed using ImageJ and the pipeline was automated using a
macro. Image stacks in the appropriate channels were convolved with a Gaussian blur (σ¼2) to reduce the effects of detector noise, then thresholded using Li's Minimum
Cross Entropy thresholding method. This was applied to areas that include all of the labelled membrane while excluding as much background as possible. The mean intensity
value of thresholded areas in the stack was calculated. (B) Representative embryos from the quantitative analysis depicted in A. (C) Ectopic expression of Nanog (white
arrows) in outside cells of Cdx2maternal-zygotic null (N¼29) but not in control (Cdx2loxP) embryos. (D) Positive Cdx2 antibody control showing immunoﬂuorscent detection
of Cdx2 in trophoblast stem (TS) cells (top panel), and negative antibody control in E3.5 blastocyst (bottom panel) showing Cdx2 restriction to outer (TE) cells and omission
from the ICM (indicated with dashed line).
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when embryos develop normally until the late blastocyst stage
(Ralston and Rossant, 2008; Strumpf et al., 2005). These results
indicate a role for maternally provided Cdx2 in development
before the blastocyst stage.
Cdx2 is required for the morula to blastocyst stage transition in vitro
To determine the exact stage of the developmental arrest of
Cdx2 maternal-zygotic knockout embryos, we next wished to
monitor their progression from the 2-cell stage until the blastocyst
stage. In order to observe the developing embryos continuously,
we used time-lapse microscopy. Individual embryos were allo-
cated to individual interstices of grids in a culture chamber so that
the development of each embryo could be tracked before being
genotyped. This allowed us to gather as much information as
possible about successive stages of pre-implantation development
of all individually genotyped embryos (Fig. 2B). We found that
from 32 Cdx2 maternal-zygotic knockout embryos, 69% arrested
development at the morula stage (Cdx2Δ/Cdx2Δ embryos from
Cdx2loxP/Cdx2Δ; Zp3-Cre mothers; Fig. 2C), in agreement with our
in vivo experiments above. This was in contrast to wild-type
embryos of which 90% (N¼10) developed to the blastocyst stage
(Control group 2, progeny of Cdx2loxP/Cdx2loxP parents; Figs. 2C;
p¼0.002, 2-tail Fisher exact test). We found that 55% (N¼20) of
Cdx2maternal only knockout embryos (Cdx2loxP/Cdx2Δ) arrested at
the morula stage, in contrast to only 14% of Cdx2 zygotic only
knockout embryos obtained by Cdx2þ/ intercrosses (Cdx2/ ,
Control group 3; N¼7). Together these results suggest that
maternal Cdx2 contributes to normal development from the
morula to the blastocyst stage.
Cell death in maternal and zygotic Cdx2 knockout embryos
In order to understand the developmental failure of Cdx2maternal-
zygotic knockout embryos, we analysed time-lapse recordings. This
revealed that while in wild-type embryos cell death does not occur
until the late blastocyst stage, in Cdx2 maternal-zygotic knockout
embryos cell death occurs much earlier, at the morula stage (Fig. 2D,
arrows). To conﬁrm this observation, we next cultured Cdx2 maternal
and maternal-zygotic knockout embryos in the presence of Sytox, a
ﬂuorescent nucleic acid stain which allows detection of cell death
in vivo by time-lapse microscopy. To ensure that the embryos were of
highest possible quality, embryos were recovered from naturally
mated rather than super-ovulated Cdx2loxP/Cdx2Δ; Zp3-Cre females.
We analysed development of 25 embryos, fromwhich wewere able to
genotype 16, from which 10 were Cdx2 maternal-zygotic knockout
embryos and 6 their heterozygous Cdx2 maternal only knockout
siblings (the remaining embryos were lost during procedure or the
genotyping result was ambiguous). This revealed that the absence of
both maternal and zygotic Cdx2 led to a signiﬁcantly higher number of
dead cells compared to maternal depletion alone (4.1 cells per embryo
versus 1.7 cells per embryo, respectively; po0.005, 2-tail Fisher exact
test). Together these results indicate that total loss of Cdx2 leads to cell
death prior to blastocyst formation.
Cdx2 is required for correct TE speciﬁcation
In order to determine the effect of depletion of both maternal and
zygotic Cdx2 expression on lineage speciﬁcation, we examined the
expression of two lineage markers; the TE marker cytokeratin-8
(recognised by TROMA-1 antibody) and the ICM marker, Nanog. We
found that cytokeratin-8 expression was either totally absent or
signiﬁcantly weaker in Cdx2 maternal-zygotic knockout embryos in
comparison to control embryos (Figs. 3A and B). Immunostaining also
conﬁrmed the loss of the Cdx2 TE marker, as expected (Figs. 3A, B, and
D). To quantify the decrease in TROMA-1 staining, we have measured
the ﬂuorescent signal intensity using ImageJ and an automated macro
by which image stacks were convolved with a Gaussian blur to reduce
detector noise effects and then thresholded for calculation of the mean
intensity. These analyses conﬁrmed a signiﬁcant decrease in
cytokeratin-8 expression in Cdx2 maternal-zygotic knockout and
maternal knockout embryos in comparison to Cdx2Δ/Cdx2loxP and
Cdx2loxP/Cdx2loxP control embryos that developed for the same period
of time (po0.05, Student's t-test). Immunoﬂuorescence for the ICM
marker Nanog in Cdx2 maternal-zygotic knockout embryos revealed
its ectopic expression in outside cells (Fig. 3C), in agreement with the
role of Cdx2 in down-regulating pluripotency genes. These results
indicate that Cdx2 is important for the speciﬁcation of the TE lineage.
Discussion
To address when Cdx2 function is required in early mouse
development we have eliminated both maternal and zygotic Cdx2
expression to determine if this would result in an earlier pheno-
type than previously reported for Cdx2 zygotic null embryos,
which progress normally to the blastocyst stage (Ralston and
Rossant, 2008; Strumpf et al., 2005). To this end, we have used a
ZP3-cre/loxP strategy that eliminates Cdx2 from the oocyte and
time-lapse imaging to record individual embryos throughout pre-
implantation development. This revealed that Cdx2 maternal-
zygotic null embryos show signiﬁcantly reduced developmental
potential to the blastocyst stage, increased cell death and failure of
the speciﬁcation of the TE lineage. This lethal phenotype of Cdx2
maternal-zygotic null embryos occurred irrespective of whether
embryos were allowed to develop in vivo or in vitro. This leads us
to conclude that Cdx2 is important for correct development of the
pre-implantation embryo due to a role in the speciﬁcation of TE
lineage from the morula stage.
The ﬁndings we report here differ from the conclusion of a
study examining the consequences of depleting maternal Cdx2
(Blij et al., 2012). It is unlikely that this difference reﬂects the
effects of embryo culture conditions because we observe the same
developmental lethality whether embryos develop in vivo or
in vitro. It is possible that differences in the methods of analysis
contributed to the apparent difference in outcome. In assessing
developmental potential of Cdx2 maternal knockout embryos, Blij
et al. (2012) reported no difference in litter size between wild-type
females and maternal knockout females mated to wild-type males
(7.371.5 and 7.070.5, respectively). By contrast, we found that
40% (N¼10) of embryos deﬁcient for only maternal Cdx2, and yet
having zygotic expression of Cdx2, failed to develop to the
blastocyst stage, compared with only 12% (N¼17) of a control
group within the same period of time. When the contribution of
both maternal and zygotic Cdx2 were depleted (N¼8), we found
that none of the embryos developing in vivo reached the
blastocyst stage.
Another possibility is the number of embryos examined. Blij et al.
(2012) cultured 11 Cdx2maternal-zygotic null and 10 Cdx2 zygotic null
embryos together and reported no differences in their development
from the single cell to the blastocyst stage. We made time-lapse
recordings of 32 individual Cdx2 maternal-zygotic and 20 individual
maternal null embryos. This revealed that the majority (69%, N¼32) of
the Cdx2 maternal-zygotic null and 55% (N¼20) of the maternal null
embryos did not reach the blastocyst stage within 3 days of culture
starting from the 2-cell stage. In comparison, only 15% of Cdx2 zygotic
null embryos (N¼7) and 7% of control group embryos (N¼28) failed
to reach the blastocyst stage within the same period of time. These
results indicate that Cdx2 is important for efﬁcient development to the
blastocyst stage.
Our time-lapse experiments revealed cell death in the Cdx2
maternal-zygotic null embryos at the morula stage whereas cell
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death does not occur at this developmental stage in wild-type
embryos. We also found that the Cdx2 maternal-zygotic null
embryos showed either absent or signiﬁcantly reduced expression
of the classic TE maker cytokeratin-8 together with expression of
the pluripotent marker, Nanog, in outside cells, suggesting failure
in TE speciﬁcation, in agreement with earlier Cdx2 down-
regulation studies from the 2-cell stage (Jedrusik et al., 2010).
Taken together, the ﬁndings we report here provide evidence that
total depletion of Cdx2 compromises pre-implantation develop-
ment, both in vivo and in vitro, and that this is associated with
increased cell death and defects in TE speciﬁcation starting in
morula stage embryos. These results lead us to conclude that Cdx2
is involved in normal embryonic development of the mouse before
the blastocyst stage.
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